# Aurinia Pharmaceuticals Inc.: filings

AUPH · Nasdaq · CIK 1600620 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/auph.md) · [Financials](/companies/auph/financials.md) · [Filings](/companies/auph/filings.md) · [Insiders](/companies/auph/insiders.md)

## Reports and events: 330 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (6-K 204, 4 150, 8-K 56, 3 29, SC 13D/A 20, 10-Q 17, SUPPL 16, SC 13G 15, SC 13G/A 13, DEFA14A 9, S-8 8, 144 7, PX14A6G 7, 10-K 6, 40-F 6, DEF 14A 6, SCHEDULE 13D/A 6, SC 13D 5, 4/A 4, F-X 4, EFFECT 3, F-10 3, F-10/A 3, 10-K/A 2, 8-K/A 2, 40-F/A 1, 40FR12B 1, 40FR12B/A 1, 6-K/A 1, ARS 1, CERTNAS 1, D 1, FWP 1, PRE 14A 1, S-3ASR 1, SCHEDULE 13G/A 1, SC TO-T 1, SC TO-T/A 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-30 | 08:03 ET | [8-K](/filings/0001600620-26-000074.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001600620-26-000074 |
| 2026-08-26 | 21:24 ET | [SCHEDULE 13D/A](/filings/0001104659-26-101785.md) | Ownership report, active investor, amended | 0001104659-26-101785 |
| 2026-08-19 | 16:11 ET | [8-K](/filings/0001600620-26-000066.md) | 8.01 Other events | 0001600620-26-000066 |
| 2026-08-06 | 08:16 ET | [10-Q](/filings/0001600620-26-000062.md) | Quarterly report, period 2026-06-30 | 0001600620-26-000062 |
| 2026-08-06 | 08:03 ET | [8-K](/filings/0001600620-26-000059.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001600620-26-000059 |
| 2026-06-04 | 18:44 ET | [SCHEDULE 13D/A](/filings/0001214659-26-007175.md) | Ownership report, active investor, amended | 0001214659-26-007175 |
| 2026-06-04 | 16:18 ET | [8-K](/filings/0001600620-26-000053.md) | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001600620-26-000053 |
| 2026-05-11 | 09:20 ET | [8-K](/filings/0001140361-26-020402.md) | 2.01 Completion of an acquisition or disposition; 9.01 Financial statements and exhibits | 0001140361-26-020402 |
| 2026-05-07 | 08:23 ET | [10-Q](/filings/0001600620-26-000049.md) | Quarterly report, period 2026-03-31 | 0001600620-26-000049 |
| 2026-05-07 | 08:22 ET | [8-K](/filings/0001600620-26-000048.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001600620-26-000048 |
| 2026-04-21 | 16:31 ET | [DEF 14A](/filings/0001600620-26-000039.md) | Proxy statement, period 2026-06-03 | 0001600620-26-000039 |
| 2026-04-03 | 16:56 ET | [8-K](/filings/0001600620-26-000035.md) | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001600620-26-000035 |
| 2026-03-25 | 16:15 ET | [SCHEDULE 13D/A](/filings/0001214659-26-003784.md) | Ownership report, active investor, amended | 0001214659-26-003784 |
| 2026-03-23 | 08:03 ET | [8-K](/filings/0001600620-26-000026.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001600620-26-000026 |
| 2026-03-03 | 17:30 ET | [SCHEDULE 13D/A](/filings/0001214659-26-002769.md) | Ownership report, active investor, amended | 0001214659-26-002769 |
| 2026-02-26 | 06:06 ET | [10-K](/filings/0001600620-26-000017.md) | Annual report, period 2025-12-31 | 0001600620-26-000017 |
| 2026-02-26 | 06:02 ET | [8-K](/filings/0001600620-26-000015.md) | 2.02 Results of operations | 0001600620-26-000015 |
| 2025-11-04 | 08:00 ET | [8-K](/filings/0001600620-25-000108.md) | 2.02 Results of operations | 0001600620-25-000108 |
| 2025-11-04 | 06:06 ET | [10-Q](/filings/0001600620-25-000106.md) | Quarterly report, period 2025-09-30 | 0001600620-25-000106 |
| 2025-08-13 | 21:40 ET | [SCHEDULE 13D/A](/filings/0001104659-25-077809.md) | Ownership report, active investor, amended | 0001104659-25-077809 |
| 2025-07-31 | 06:10 ET | [10-Q](/filings/0001600620-25-000092.md) | Quarterly report, period 2025-06-30 | 0001600620-25-000092 |
| 2025-07-31 | 06:01 ET | [8-K](/filings/0001600620-25-000090.md) | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001600620-25-000090 |
| 2025-06-30 | 06:03 ET | [8-K](/filings/0001600620-25-000083.md) | 8.01 Other events | 0001600620-25-000083 |
| 2025-05-15 | 16:06 ET | [8-K](/filings/0001600620-25-000057.md) | 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results | 0001600620-25-000057 |
| 2025-05-12 | 06:05 ET | [10-Q](/filings/0001600620-25-000049.md) | Quarterly report, period 2025-03-31 | 0001600620-25-000049 |
| 2025-05-12 | 06:02 ET | [8-K](/filings/0001600620-25-000047.md) | 2.02 Results of operations | 0001600620-25-000047 |
| 2025-04-17 | 16:02 ET | [DEF 14A](/filings/0001600620-25-000032.md) | Proxy statement, period 2025-05-15 | 0001600620-25-000032 |
| 2025-03-04 | 17:04 ET | [SCHEDULE 13D/A](/filings/0001214659-25-003856.md) | Ownership report, active investor, amended | 0001214659-25-003856 |
| 2025-02-27 | 06:12 ET | [10-K](/filings/0001600620-25-000011.md) | Annual report, period 2024-12-31 | 0001600620-25-000011 |
| 2025-02-27 | 06:05 ET | [8-K](/filings/0001600620-25-000009.md) | 2.02 Results of operations | 0001600620-25-000009 |
| 2024-11-07 | 06:17 ET | [10-Q](/filings/0001600620-24-000108.md) | Quarterly report, period 2024-09-30 | 0001600620-24-000108 |
| 2024-11-07 | 06:13 ET | [8-K](/filings/0001600620-24-000106.md) | 2.02 Results of operations; 2.05 Exit or disposal costs; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001600620-24-000106 |
| 2024-09-12 | 16:10 ET | [SC 13D](/filings/0001214659-24-016381.md) | Ownership report, active investor | 0001214659-24-016381 |
| 2024-09-12 | 16:08 ET | [8-K](/filings/0001600620-24-000099.md) | 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001600620-24-000099 |
| 2024-08-01 | 06:07 ET | [10-Q](/filings/0001600620-24-000091.md) | Quarterly report, period 2024-06-30 | 0001600620-24-000091 |
| 2024-08-01 | 06:03 ET | [8-K](/filings/0001600620-24-000089.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001600620-24-000089 |
| 2024-06-14 | 17:25 ET | [8-K](/filings/0001600620-24-000087.md) | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001600620-24-000087 |
| 2024-05-03 | 16:08 ET | [DEF 14A](/filings/0001600620-24-000064.md) | Proxy statement, period 2024-06-14 | 0001600620-24-000064 |
| 2024-05-02 | 06:07 ET | [10-Q](/filings/0001600620-24-000051.md) | Quarterly report, period 2024-03-31 | 0001600620-24-000051 |
| 2024-05-02 | 06:03 ET | [8-K](/filings/0001600620-24-000049.md) | 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001600620-24-000049 |
| 2024-04-29 | 16:14 ET | [10-K/A](/filings/0001600620-24-000041.md) | Annual report, amended, period 2023-12-31 | 0001600620-24-000041 |
| 2024-03-20 | 17:23 ET | [SC 13D/A](/filings/0001104659-24-036780.md) | Ownership report, active investor, amended | 0001104659-24-036780 |
| 2024-02-29 | 16:10 ET | [8-K](/filings/0001600620-24-000027.md) | 5.02 Departure or appointment of officers or directors | 0001600620-24-000027 |
| 2024-02-15 | 06:16 ET | [10-K](/filings/0001600620-24-000012.md) | Annual report, period 2023-12-31 | 0001600620-24-000012 |
| 2024-02-15 | 06:06 ET | [8-K](/filings/0001600620-24-000010.md) | 2.02 Results of operations; 2.05 Exit or disposal costs; 8.01 Other events; 9.01 Financial statements and exhibits | 0001600620-24-000010 |
| 2024-01-05 | 06:02 ET | [8-K](/filings/0001600620-24-000001.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001600620-24-000001 |
| 2023-11-02 | 06:05 ET | [10-Q](/filings/0001600620-23-000044.md) | Quarterly report, period 2023-09-30 | 0001600620-23-000044 |
| 2023-11-02 | 06:01 ET | [8-K](/filings/0001600620-23-000043.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001600620-23-000043 |
| 2023-09-21 | 16:06 ET | [8-K](/filings/0001600620-23-000040.md) | 1.01 Entry into a material agreement; 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001600620-23-000040 |
| 2023-08-21 | 16:11 ET | [8-K](/filings/0001600620-23-000030.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001600620-23-000030 |

Page 1 of 7. [Older](/companies/auph/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 30, 2026, 08:08 ET. No prices; not investment advice.